Soluble human complement receptor type 1 inhibits complement-mediated host defense.
Soluble complement receptor type 1 (sCR1) is a powerful inhibitor of complement activation. Because of this ability, sCR1 may prove to be an important therapeutic agent that can be used to block the immunopathologic effects of uncontrolled complement activation in a variety of clinically significant...
Kaydedildi:
| Yayımlandı: | Clin Diagn Lab Immunol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368344/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8556505/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.1.5.585-589.1994 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|